Navigation Links
Essilor Cancels 1,600,000 Shares
Date:12/2/2008

CHARENTON-LE-PONT, France, December 3 /PRNewswire-FirstCall/ -- On November 28, Essilor cancelled 1,600,000 shares, in line with its commitment to shareholders to offset the dilutive impact of Oceane bond conversions and the Company's stock option plans.

These latest cancellations concerned shares acquired under the 6.9 million share buyback program authorized by the Board of Directors on July 15, 2008 to offset the dilutive impact of converting outstanding Oceane bonds due in 2010. To date, a total of 1.5 million shares have been bought back under this program.

At the same time, in line with its standard practice, Essilor has cancelled shares bought back on the market in order to offset the dilutive impact of its stock option plans, and also of its performance share plans which are covered by shares held in treasury stock.

Following these cancellations, Essilor's capital is represented by 210,445,678 shares.

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 270 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index (ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF FP).

    Investor Relations and Financial Communications
    Phone: +33(0)1-49-77-42-16
   http://www.essilor.com


'/>"/>
SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Essilors 2007 Third-Quarter Report
2. Essilor Cancels 700,000 Shares
3. Essilor: New Acquisitions in the United States and Brazil
4. Essilor : Nomination of Hubert Sagnieres
5. Essilors First-Half 2008 Results
6. Essilor Finalizes Satisloh Agreement
7. Jazz Pharmaceuticals Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
10. Neuralstem Shares Accepted for Trading on Amex(R)
11. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... its Chairman and CEO, Jim Joyce . ... Conference last Saturday, Bill Gates warned world ... people than nuclear weapons. Mr. Gates expressed his concern, ... agencies, that scientific terrorists have access to the necessary ...
(Date:2/24/2017)... 2017 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its unaudited financial results for the third quarter and ... 31, 2016. Third Quarter of Fiscal 2017 ... of fiscal 2017 increased by 18.6% to RMB200.9 million ...
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):